risedronic acid has been researched along with Sensitivity and Specificity in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, YH; Jeong, JH; Lim, CH; Seo, YH | 1 |
| Greiner, RA; Krieg, MA; Lamy, O; Wasserfallen, JB | 1 |
| Dejager, AD; Ghassabian, S; Smith, MT; Wright, LA | 1 |
| Appleman, S; Keelan, M; Thomson, AB; Wallace, JL | 1 |
| Kline, WF; Matuszewski, BK; Shugarts, SB; Vallano, PT; Woolf, EJ | 1 |
| Basir, YJ; Briscoe, C; Kafonek, C; Lapko, VN; Lee, JW; Olsen, R; Zhu, LS | 1 |
| Denk, E; Fattinger, K; Häuselmann, HJ; Hillegonds, D; Hurrell, RF; Kraenzlin, M; Vogel, J; Walczyk, T | 1 |
2 trial(s) available for risedronic acid and Sensitivity and Specificity
| Article | Year |
|---|---|
Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa.
Topics: Administration, Oral; Aged; Alendronate; Biomarkers; Biopsy, Needle; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Drug Administration Schedule; Etidronic Acid; Female; Gastric Juice; Gastric Mucosa; Gastroscopy; Humans; Interleukin-1; Interleukin-13; Interleukin-8; Middle Aged; Postmenopause; Reference Values; Risedronic Acid; Sensitivity and Specificity; Single-Blind Method | 2003 |
Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass.
Topics: Aged; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcium Radioisotopes; Diphosphonates; Etidronic Acid; Female; Humans; Kinetics; Osteoporosis, Postmenopausal; Postmenopause; Risedronic Acid; Sensitivity and Specificity | 2007 |
5 other study(ies) available for risedronic acid and Sensitivity and Specificity
| Article | Year |
|---|---|
UPLC-UV method for determination of risedronate in human urine.
Topics: Adult; Biological Availability; Chromatography, High Pressure Liquid; Drug Stability; Etidronic Acid; Humans; Linear Models; Reproducibility of Results; Risedronic Acid; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Young Adult | 2014 |
Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective.
Topics: Age Factors; Aged; Aged, 80 and over; Bone Density Conservation Agents; Cost-Benefit Analysis; Etidronic Acid; Female; Hip Fractures; Humans; Markov Chains; Medication Adherence; Middle Aged; Osteoporosis, Postmenopausal; Quality-Adjusted Life Years; Risedronic Acid; Risk Assessment; Sensitivity and Specificity; Spinal Fractures; Switzerland | 2008 |
Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasma.
Topics: Acetaminophen; Chromatography, High Pressure Liquid; Diazomethane; Drug Stability; Etidronic Acid; Hemolysis; Humans; Ibuprofen; Regression Analysis; Reproducibility of Results; Risedronic Acid; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Trimethylsilyl Compounds | 2012 |
Determination of risedronate in human urine by column-switching ion-pair high-performance liquid chromatography with ultraviolet detection.
Topics: Chromatography, High Pressure Liquid; Etidronic Acid; Humans; Ions; Reference Standards; Reproducibility of Results; Risedronic Acid; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2003 |
A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometry.
Topics: Alendronate; Bone Density Conservation Agents; Chromatography, High Pressure Liquid; Diazomethane; Etidronic Acid; Humans; Risedronic Acid; Sensitivity and Specificity; Tandem Mass Spectrometry | 2006 |